NuVasive, Inc. (NUVA) Tops Q3 EPS by 3c; Lowers FY11 EPS Outlook, Boosts Revs
NuVasive, Inc. (
NuVasive, Inc. sees FY2011 EPS of $1.01-$1.02, versus prior guidance of $1.09-$1.12 and the consensus of $1.05. NuVasive, Inc. sees FY2011 revenue of $538-$540 million, versus prior guidance of $530-$540 million and the consensus of $541.96 million.
NASDAQ: NUVA) reported Q3 EPS of $0.26, $0.03 better than the analyst estimate of $0.23. Revenue for the quarter came in at $132.9 million versus the consensus estimate of $134.16 million.
NuVasive, Inc. sees FY2011 EPS of $1.01-$1.02, versus prior guidance of $1.09-$1.12 and the consensus of $1.05. NuVasive, Inc. sees FY2011 revenue of $538-$540 million, versus prior guidance of $530-$540 million and the consensus of $541.96 million.